INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 September 2015
Net Assets |
£209m |
Net Assets per share |
522p |
Share price |
455p |
Total value of unquoted investments |
£21m |
Total number of portfolio companies |
99 |
Top Ten Holdings
Company Name |
% NAV |
Celgene |
9.6 |
Gilead |
8.0 |
Regeneron |
7.0 |
Biogen |
6.8 |
Incyte |
4.8 |
Alexion |
4.8 |
Amgen |
4.6 |
Opthotech |
4.3 |
Vertex |
3.7 |
Biomarin |
2.8 |
|
----------- |
Total |
56.4 |
Portfolio Profitability |
% NAV |
Profitable |
53 |
Turning Profitable 2015 |
11 |
Unprofitable |
36 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
US & Canada |
84 |
Europe & UK |
16 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
91 |
Unquoted |
9 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
2 NOVEMBER 2015